Inhibikase Therapeutics, Inc.

Historical 13F Holders

Symbol
IKT
CUSIP
45719W205
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 48 51.5 M $113 M
2024 Q4 33 50.1 M $163 M
2024 Q3 12 860 k $1.12 M
2024 Q2 14 838 k $1.02 M
2024 Q1 15 209 k $451 k
2023 Q4 13 237 k $301 k
2023 Q3 14 430 k $598 k
2023 Q2 15 747 k $2.69 M
2023 Q1 1 82.8 k $54.5 k